|
|
Volumn 18, Issue 2, 2012, Pages 190-193
|
|
The ultimate endpoint
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
DIPHENHYDRAMINE;
FLUPENTIXOL DECANOATE;
LITHIUM;
OLANZAPINE;
PLACEBO;
VALPROATE SEMISODIUM;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
BEHAVIOR THERAPY;
BIPOLAR DISORDER;
BORDERLINE STATE;
DEATH;
DEPRESSION;
DRUG COST;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE POLICY;
HUMAN;
LAW SUIT;
MAJOR DEPRESSION;
MEDICAL EDUCATION;
MENTAL HEALTH CARE PERSONNEL;
OUTCOME ASSESSMENT;
PERSONALITY DISORDER;
PRIORITY JOURNAL;
PSYCHIATRIST;
PSYCHOTHERAPY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SCHIZOAFFECTIVE PSYCHOSIS;
SCHIZOPHRENIA;
SUICIDAL BEHAVIOR;
SUICIDAL IDEATION;
SUICIDE;
SUICIDE ATTEMPT;
ANTIDEPRESSIVE AGENTS;
BIOMEDICAL RESEARCH;
CLINICAL TRIALS AS TOPIC;
HUMANS;
NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.);
SUICIDE;
UNITED STATES;
|
|
EID: 84856726522
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0212-190 Document Type: Article |
|
Times cited : (6)
|
|
References (7)
|
